Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients

NCT02939599 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated early for strategic reasons. Only Part I of the study was completed.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals